Journal of Drug Targeting

Papers
(The TQCC of Journal of Drug Targeting is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma55
Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection50
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches44
Advancement in transporter-oriented nanoplatforms for cancer therapy43
Methods for fabricating oxygen releasing biomaterials42
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma41
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis39
Novel strategies for the fight of Alzheimer’s disease targeting amyloid-β protein36
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer32
Correction29
Effect of Malt-PEG-Abz@RSL3 micelles on HepG2 cells based on NADPH depletion and GPX4 inhibition in ferroptosis26
Improved Antidiabetic Potential of Quercetin-Loaded Chitosan-Lecithin Nanoparticles for Effective Glycemic Control25
Emerging role of ferroptosis in diabetic retinopathy: a review25
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases25
Correction24
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells24
Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes24
Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer23
Absorption enhancer approach for protein delivery by various routes of administration: a rapid review22
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice22
Ferroptosis-targeting drugs in breast cancer20
Engineered extracellular vesicle with RAGE-antagonist peptide for delivery of anti-miRNA155 oligonucleotides to inflammatory lung cells20
Protective effects of BP-1-102 against intracranial aneurysms-induced impairments in mice20
Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide19
Micro and nanorobot-based drug delivery: an overview19
Interactions and communications in lung tumour microenvironment: chemo/radiotherapy resistance mechanisms and therapeutic targets19
Stimulus-responsive peptide hydrogels: a safe and least invasive administration approach for tumor treatment18
Erythrocyte-derived liposomes for the treatment of inflammatory diseases18
Dehydrocurvularin-loaded mPEG-PLGA nanoparticles for targeted breast cancer drug delivery: preparation, characterization, in vitro , and in vivo 18
Redefining hepatocellular carcinoma treatment: nanotechnology meets tumor immune microenvironment18
siRNA targeting PARP-1 alleviates diabetic peripheral neuropathy in a streptozotocin-induced rat model18
Crafting two-dimensional materials for contrast agents, drug, and heat delivery applications through green technologies18
Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy16
Identifying factors controlling cellular uptake of gold nanoparticles by machine learning16
Isoform-specific vs. isoform-universal drug targeting: a new targeting paradigm illustrated by new anti-ICAM-1 antibodies16
Comprehensive insights into herbal P-glycoprotein inhibitors and nanoformulations for improving anti-retroviral therapy efficacy16
Formulation, optimisation, and evaluation of Lornoxicam-loaded Novasomes for targeted ulcerative colitis therapy: in vitro and in vivo investigations16
Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells15
pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery15
Targeted delivery of epirubicin to cancerous cell using copper sulphide nanoparticle coated with polyarginine and 5TR1 aptamer15
In vivo application of magnetic molecularly imprinted polymer in rheumatoid arthritis rat model15
From adhesion to invasion: the multifaceted roles of Mycobacterium tuberculosis lipoproteins14
Emerging biologics for the treatment of pulmonary arterial hypertension14
An overview of phospholipid enriched-edge activator-based vesicle nanocarriers: new paradigms to treat skin cancer14
The role of green synthesis metal and metal oxide nanoparticles in oral cancer therapy: a review13
microRNAs: critical targets for treating rheumatoid arthritis angiogenesis13
Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review13
Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review13
Angiopep-2 modified dual drug-loaded liposomes with brain targeting functionality mitigate Alzheimer’s disease-related symptoms in APP/PS-1 mice13
Study on lipid nanomicelles targeting placenta for the treatment of preeclampsia12
Mesencephalic astrocyte-derived neurotrophic factor restores blood–brain barrier integrity of aged mice after ischaemic stroke/reperfusion through anti-inflammation via TLR4/MyD88/NF-κB pathway12
Recent advances in curcumin-based nanoformulations in diabetes12
Lipo/TK-CDN/TPP/Y6 nanoparticles inhibit cutaneous melanoma formation12
A novel micellar carrier to reverse multidrug resistance of tumours: TPGS derivatives with end-grafted cholesterol12
Recent developments in nanoparticles for the treatment of diabetes12
Non-coding RNAs enhance the apoptosis efficacy of therapeutic agents used for the treatment of glioblastoma multiform12
Research progress of p38 as a new therapeutic target against morphine tolerance and the current status of therapy of morphine tolerance11
Multi-strategic approaches for enhancing active transportation using self-emulsifying drug delivery system11
Drug repurposing strategies and key challenges for COVID-19 management11
Folate receptor-mediated targeted therapy for rheumatoid arthritis by methotrexate-phospholipid complex nano-emulsions11
Exploring the translocation behaviours in vivo of herpetrione amorphous nanoparticles via oral delivery11
Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac)11
Smart delivery of epirubicin to cancer cells using aptamer-modified ferritin nanoparticles11
Valeric acid reduction by chitosan oligosaccharide induces autophagy in a Parkinson’s disease mouse model10
In vitro studies support clinical trials showing platelet-rich fibrin-mediated local delivery of antibiotics improves outcomes in impacted mandibular third molar surgery10
Ultrasound image-guided gene delivery using three-dimensional diagnostic ultrasound and lipid-based microbubbles10
Edoxaban enfolded beta-1,4-poly- d -glucosamine nanoparticles for targeting eponym Stuart–Prower factor for treatment of venous thrombosis10
Methotrexate-Loaded solid lipid nanoparticles enhance the viability of cutaneous flaps: potential for surgical wound healing10
Exosome-mediated transfer of circHIPK3 promotes trastuzumab chemoresistance in breast cancer10
MicroRNA-206 inhibition and activation of the AMPK/Nampt signalling pathway enhance sevoflurane post-conditioning-induced amelioration of myocardial ischaemia/reperfusion injury10
Green synthesis of magnesium oxide nanoparticles using the extract of Falcaria vulgaris to enhance the healing of burn wounds10
Lymphatic targeting for therapeutic application using nanoparticulate systems10
Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model9
ROS1-positive non-small cell lung cancer (NSCLC): biology, diagnostics, therapeutics and resistance9
Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix9
Light mediated drug delivery systems: a review9
Targeted therapy of tumour microenvironment by gold nanoparticles as a new therapeutic approach9
Nanoparticle-Based gene therapy strategies in retinal delivery9
Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumour-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer9
The combined treatment of gold nanoparticles associated with photobiomodulation accelerate the healing of dermonecrotic lesion9
ceRNA networks in gynecological cancers progression and resistance9
Development of mRNA nano-vaccines for COVID-19 prevention and its biochemical interactions with various disease conditions and age groups9
A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches9
Nanotransethosomal dual-drug loaded gel of methotrexate and mangiferin as a potent synergistic intervention for rheumatoid arthritis via transdermal delivery9
Integrating machine learning and multitargeted drug design to combat antimicrobial resistance: a systematic review8
Anti-GPC3 antibody and cell-penetrating peptide CPP44 dual-ligand modified liposomes for targeted delivery of arsenic trioxide in the treatment of hepatocellular carcinoma8
Development of linagliptin-loaded liposomes using aspartic acid conjugate for bone-targeted delivery to combat osteoporosis8
2,2,6,6-tetramethylpiperidin-1-oxyl: a new potential targeted ligand based on lipid peroxidation for targeted drug delivery8
Role of liposomes in chemoimmunotherapy of breast cancer8
Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway8
3D printing technology in healthcare: applications, regulatory understanding, IP repository and clinical trial status8
Aptamers: ushering in new hopes in targeted glioblastoma therapy8
Advancements in colorectal cancer immunotherapy: from CAR-T cells to exosome-based therapies8
Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target8
Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy8
0.066659927368164